Research Interests:HIV/AIDS, International Health, Infectious Diseases.
Alan Lifson received his M.D. from the University of California- San Francisco and his M.P.H. from the University of California- Berkeley. His research interests in infectious disease epidemiology include HIV/AIDS and international health. His current research includes the clinical epidemiology of HIV in various settings. He is also clinical director of the Minnesota site for the Midwest AIDS Training and Education Center. He has taught, consulted, or conducted research on HIV and other infectious diseases in Africa, Eastern Europe, the Caribbean, and Asia. He teaches a course on infectious disease epidemiology.
- M.D. in Medicine, University of California, San Francisco, CA
- M.P.H. in Epidemiology, University of California, Berkeley, CA
- B.A. in Psychology, University of Michigan, Ann Arbor, MI
Infectious Disease: HIV / AIDS
- 2003-Present: Professor, Division of Epidemiology and Community Health, School of Public Health, University of Minnesota
- 2003-Present: Adjunct Professor, Division of Infectious Diseases, School of Medicine, University of Minnesota
- 2000-2003: Associate Professor, Professor, Division of Infectious Diseases, School of Medicine, University of Minnesota
- 1998-2000: Chief, Acute Disease Prevention Services Section, Minnesota Department of Health
- 1993-1998: Associate Professor, Division of Epidemiology, School of Public Health, University of Minnesota
- 1990-1993: Assistant, Associate Professor, Department of Epidemiology and Biostatistics, School of Medicine, Univ California, San Francisco
- 1987-1990: Chief, Research Branch, AIDS Office, Department of Health, San Francisco, CA
- 1985-1987: Epidemic Intelligence Service Officer, AIDS Program, Centers for Disease Control
- 2014 All-University Award for Global Engagement
The all-University Award for Global Engagement is given to University of Minnesota faculty and staff members in recognition of outstanding contributions to global education and international programs at the University or in their field or discipline. In addition to honoring individual faculty and staff members, the award—by identifying excellence in global engagement and by recognizing outstanding work—serves as a resource and inspiration to other faculty and staff.
- 2015 Leonard M. Schuman Award for Excellence in Teaching, School of Public Health, University of Minnesota
- Lifson AR, Demissie W, Ketema K, et al. Failure to test for HIV in rural Ethiopia: Knowledge and belief correlates and implications for universal test and treat strategies. J Int Assoc Physicians AIDS Care 2013 Jun 6. [Epub ahead of print]
- Lifson AR, Demissie W, Tadesse A, et al. Barriers to retention in care as perceived by persons living with HIV in rural Ethiopia: Focus groups results and recommended strategies. J Int Assoc Physicians AIDS Care 2013;12:32-38.
- Lifson AR, Lando HA. Smoking and HIV: Prevalence, health risks and cessation strategies. Current HIV/AIDS Rep 2012;9:223-30.
- Lifson AR, Demissie W, Tadesse A, et al. HIV/AIDS stigma-associated attitudes in a rural Ethiopian community: Characteristics, correlation with HIV knowledge and other factors, and implications for community intervention. BMC Intl Health Human Rights 2012;12:6.
- Lifson AR, Krantz EM, Grambsch PL, et al. Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. Military prospective HIV cohort. AIDS Research and Therapy 2012;9:4.
- Lifson AR, Krantz EM, Eberly LE, et al. Long-term CD4+ lymphocyte response following HAART initiation in a U.S. military prospective cohort. AIDS Research and Therapy 2011;8:2.
- Lifson AR, and INSIGHT Endpoint Review Committee Writing Group. Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. HIV Clinical Trials. 2010;11:205-19.
- Lifson AR, Neuhaus J, Arribas JR, van den M Berg-Wolf M, Labriola AM, Read TRH. Smoking-related risk of all-cause mortality and serious clinical events among HIV-infected patients receiving highly active antiretroviral therapy in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Pub Health 2010;100:1896-903.